ClinicalTrialsFinder

Spindle Cell/Sclerosing Rhabdomyosarcoma Clinical Trials in Chicago, Illinois

1 recruitingChicago, Illinois

Showing 1–1 of 1 trials

Recruiting
Phase 3

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Embryonal RhabdomyosarcomaFusion-Negative Alveolar RhabdomyosarcomaSpindle Cell/Sclerosing Rhabdomyosarcoma
Children's Oncology Group205 enrolled179 locationsNCT05304585